WestBridge Capital has led an approximately USD 29m Series B round for Indian small business financial technology provider Vyapar. The company is now valued at around USD 118m.
The Chinese manufacturer of plant-based protein replacements has secured USD 100m in funding to advance a product portfolio that aspires to diversity and structural sophistication
Policy volatility in China has prompted many investors to eschew consumer-facing business models in favour of B2B plays like deep-tech, but sector specialists still see opportunity, the Hong Kong Venture Capital & Private Equity Association’s (HKVCA)...
Indonesian micro-savings and micro-investment app Pluang has raised USD 55m in Series B funding led by Accel. It follows a USD 55m Series B investment led by Square Peg Capital last year.
Tiger Global Management has led a USD 82m Series B round for Refyne, an India-based early wage access (EWA) platform. Existing backers QED Investors, RTP Global, Jigsaw VC, Digital Horizon VC, and XYZ Capital also took part, as did partners from DST Global.
Recykal, a software provider for the waste management and recycling industries, has raised USD 22m in funding led by Morgan Stanley India Infrastructure.
Tiger Global Management has led a USD 45m Series B round for India’s Avataar, a company that uses 3D augmented reality (AR) displays to help e-commerce customers browse large items online.
Five Elms Capital, a specialist growth investor in software start-ups globally, has led a USD 32m Series B round for New Zealand and US-based customer feedback platform AskNicely.
Sygnum, a Singapore and Switzerland-based digital asset bank, has raised a Series B of USD 90m - at a post-money valuation of USD 800m - led by Hong Kong-based investor Sun Hung Kai & Co.
Singapore-based Virtue Diagnostics, a clinical testing equipment supplier for China and developing markets, has raised a USD 100m Series B round led by Sequoia Capital China and Morningside Ventures.
Australia-based Square Peg Capital has led a USD 20m investment in digital banking start-up Timo, which claims to be the first Vietnamese player in this space.
Zupee, an Indian skill-based gaming platform, has raised a USD 72m Series B extension, taking the overall round to USD 102m. The company is now valued at USD 600m.
GlobalBees, an India-based platform that agglomerates technology-enabled emerging consumer brands, has raised USD 111.5m in Series B funding at a valuation of USD 1.1bn.
GenFleet Therapeutics, a Chinese biotech developer focused on oncology and immunology, has secured a USD 75m Series C round led by Huagai Capital.
Australia’s Blackbird Ventures has led a $25 million Series B round for Inventia Life Science, a local start-up that provides 3D cell cultures for research and clinical purposes.
General Catalyst has led a $70 million Series A round for Uni, an Indian buy now, pay later (BNPL) start-up that launched its flagship product just six months ago.
Fuse, which claims to be Indonesia’s largest insurance technology start-up, has raised $25 million in a Series B extension. It comes within six months of a $50 million Series B featuring East Ventures.
Hong Kong accelerator Brinc has raised $130 million for blockchain-related accelerator programs and a global expansion with support from Animoca Brands, a local segment leader backed by several VCs.
Green-tech investment, from electric vehicles to renewable energy, is already in the ascendency as China ponders a carbon-neutral future. Momentum is expected to grow in 2022
Software-as-a-service continues to benefit from a digitalization push across multiple markets. Investors are looking for differentiation in a market characterized by high valuations and intense competition
T11, a China-based, technology-enabled supermarket chain, has raised a $100 million Series B led by Alibaba Group. Other investors include Redview Capital and MSA Capital.
Richard Li, president of Legend Capital, on evolving US-China relations, the logic behind the recent wave of regulation, investing in line with government policy, and why LPs should get used to onshore exits
Avistone Pharmaceuticals, a Beijing biotech company focused on precision oncology therapeutics has raised more than $200 million in a Series A funding round led by Vivo Capital.
Insight Partners has made its first investment in Indonesia, co-leading a $48 million Series B round for consumer payments platform Flip alongside Sequoia Capital India and Insignia Venture Partners.